康希诺生物(06185)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06185 康希诺生物

未开盘 11-18 16:08:08

28.250

-0.700

-2.42%

最高29.300	最低28.050	成交量108.04万
今开29.100	昨收28.950	日振幅4.32%
总市值69.90亿	流通市值37.57亿	总股本2.47亿
成交额3,085万	换手率0.81%	流通股本1.33亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06185","market":"HK","secType":"STK","nameCN":"康希诺生物","latestPrice":28.25,"timestamp":1731917288020,"preClose":28.95,"halted":0,"volume":1080401,"delay":0,"floatShares":133000000,"shares":247449899,"eps":-6.4731536,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.7,"latestTime":"11-18 16:08:08","open":29.1,"high":29.3,"low":28.05,"amount":30846308,"amplitude":0.043178,"askPrice":28.25,"askSize":1200,"bidPrice":28.2,"bidSize":8400,"shortable":3,"etf":0,"ttmEps":-3.14142887868291,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731979800000},"adr":0,"listingDate":1553702400000,"adjPreClose":28.95,"dividendRate":0.031967,"openAndCloseTimeList":[[1731893400000,1731902400000],[1731906000000,1731916800000]],"volumeRatio":0.3026405729790467,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688185","market":"SH","secType":"STK","nameCN":"康希诺","latestPrice":61.94,"timestamp":1731913200000,"preClose":63.96,"halted":0,"volume":2437068,"delay":0,"premium":"-57.65"}},"requestUrl":"/m/hq/s/06185/tweets","defaultTab":"tweets","newsList":[{"id":"2484466618","title":"金十数据整理：每日港股市场要闻速递（11月18日 周一）","url":"https://stock-news.laohu8.com/highlight/detail?id=2484466618","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484466618?lang=zh_cn&edition=full","pubTime":"2024-11-18 09:03","pubTimestamp":1731891836,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0266","688180","BK0028","159646","LU0531971595.HKD","09988","BK1502","01898","LU0791590937.USD","LU0797268264.HKD","01877","LU0594300179.USD","IE00BZ08YT58.USD","LU1152091168.USD","601898","LU0449509016.USD","LU0345775950.USD","LU1794554557.SGD","SG9999001051.SGD","LU0181495838.USD","YANG","09618","00984","LU0231483743.USD","HBBD.SI","SG9999002828.SGD","03347","06185","LU1008478684.HKD","LU1770036033.HKD","BK1575","BK0188","HSTECH","BABA","BK4554","03398","BK1608","HSCEI","89988","LU1831875114.USD","LU1481107354.HKD","LU0737861772.HKD","JD","LU1568876251.USD","02429","89618","LU0708995153.HKD","07226","LU1568876335.HKD","LU0214875030.USD"],"gpt_icon":0},{"id":"2484650976","title":"【湾区早参】香港与内地资本市场互联互通机制迎来十周年；香港与秘鲁签订自由贸易协定","url":"https://stock-news.laohu8.com/highlight/detail?id=2484650976","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484650976?lang=zh_cn&edition=full","pubTime":"2024-11-18 08:31","pubTimestamp":1731889902,"startTime":"0","endTime":"0","summary":"在港股通方面，截至2024年9月底，南向资金累计净流入近3.4万亿港元。期内集团收入10.55亿元，同比增长36.01%。期内，货邮周转量同比上升21.08%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/YjE5MTg4YjVmOWZlYmUxNDMyNzYzODgyMzAy.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjE5MTg4YjVmOWZlYmUxNDMyNzYzODgyMzAy.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947854","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1538","01336","00753","159982","BK1550","BK1161","BK1137","BK1514","BK1561","01898","BK1184","BK1191","BK1590","BK1123","01860","BK1586","BK1594","00670","01088","BK1584","LU0173614495.USD","BK1574","LU0287142896.SGD","BK1178","BK1515","BK1505","BK1555","BK1518","06185","399300","06660","01055","02777","BK1240"],"gpt_icon":0},{"id":"2483346135","title":"【港股通】康希诺生物(06185)冻干b型流感嗜血杆菌结合疫苗启动I期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2483346135","media":"金吾财讯","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483346135?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:53","pubTimestamp":1731660790,"startTime":"0","endTime":"0","summary":"金吾财讯 | 康希诺生物(06185)公布，公司冻干b型流感嗜血杆菌结合疫苗(Hib疫苗)于近日正式启动I期临床试验，并完成首例受试者入组。公司研发的Hib疫苗系以纯化的Hib荚膜多糖与破伤风类毒素蛋白共价结合而成，采用冻干剂型，预期可在接种后诱导针对Hib的体液免疫，对接种者提供保护作用。公司正在研发以组分百白破为基础的联合疫苗，在研Hib疫苗为其中的组成部分，作为未获批上市的单苗需累积一定的临床数据，以支持未来以组分百白破为基础的联合疫苗的注册申报。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/MTU2NzYxOTI1Mjg5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MTU2NzYxOTI1Mjg5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947839","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","HSCEI","BK1515","BK1161","BK1191","BK1574","03347","159646","06185","BK1583","HSTECH","BK1576","YANG"],"gpt_icon":0},{"id":"2483346971","title":"康希诺生物(06185)：冻干b型流感嗜血杆菌结合疫苗启动I期临床试验并完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2483346971","media":"智通财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483346971?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:50","pubTimestamp":1731660648,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康希诺生物 发布公告，公司研发的冻干b型流感嗜血杆菌结合疫苗于近日正式启动I期临床试验，并完成首例受试者入组。流感嗜血杆菌为革兰阴性杆菌，是儿童急性下呼吸道感染最主要的病塬菌之一，分为有荚膜型和无荚膜型，两者均可引发感染。有荚膜的菌株根据荚膜多糖的化学成分来进行分类，迄今已发现6种血清型，其中，约95%的侵袭性流感嗜血杆菌疾病由b型引起。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211527.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","06185","03347","BK1191","BK1574","159646","BK1576","BK1161","BK1515","BK1141"],"gpt_icon":0},{"id":"2483349476","title":"康希诺生物(06185.HK)预防急性下呼吸道感染疫苗完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2483349476","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483349476?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:46","pubTimestamp":1731660360,"startTime":"0","endTime":"0","summary":"康希诺生物(06185.HK) 公布，旗下“冻干b型流感嗜血杆菌结合疫苗”(Hib疫苗)于近日正式启动I期临床试验，并完成首例受试者入组。据介绍，流感嗜血杆菌为革兰阴性杆菌，是儿童急性下呼吸道感染最主要的病原菌之一。至于上述疫苗预期可在接种后，诱导针对Hib的体液免疫，对接种者提供保护作用。康希诺生物表示，正在研发以组分百白破为基础的联合疫苗，在研Hib疫苗为其中的组成部分，作为未获批上市的单苗需累积一定的临床数据，以支持未来以组分百白破为基础的联合疫苗的注册申报。(js/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-15 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230120154912506_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230120154912506_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1397075/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06185","BK1191","BK1515","BK1161","159646","BK1574"],"gpt_icon":0},{"id":"2483117398","title":"康希诺生物(06185)下跌5.06%，报30.05元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483117398","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483117398?lang=zh_cn&edition=full","pubTime":"2024-11-14 14:06","pubTimestamp":1731564380,"startTime":"0","endTime":"0","summary":"11月14日，康希诺生物(06185)盘中下跌5.06%，截至14:06，报30.05元/股，成交2989.85万元。康希诺生物股份公司是一家专注于疫苗研发、生产和商业化的高科技生物制品企业，其主要产品包括新冠疫苗、四价流脑结合疫苗、二价流脑结合疫苗和重组埃博拉病毒病疫苗等。公司已在香港和上海两地上市，拥有全球创新的五大技术平台，已建立数十条产品研发管线，并在中国天津、上海以及墨西哥、巴基斯坦、马来西亚等国家建立了大规模现代化疫苗产业基地。截至2024年三季报，康希诺生物营业总收入5.67亿元、净利润-2.22亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/14140645282637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","06185","BK1161","BK1515","BK1574"],"gpt_icon":0},{"id":"2483811182","title":"康希诺生物盘中异动 下午盘快速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483811182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483811182?lang=zh_cn&edition=full","pubTime":"2024-11-14 14:06","pubTimestamp":1731564375,"startTime":"0","endTime":"0","summary":"2024年11月14日下午盘14时06分，康希诺生物股票出现波动，股价快速下挫5.06%。截至发稿，该股报30.050港元/股，成交量96.0755万股，换手率0.72%，振幅6.64%。机构评级方面，在所有8家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康希诺生物股票所在的生物技术行业中，整体跌幅为1.19%。康希诺生物公司简介：许可项目:第三类医疗器械经营;药品生产;药品进出口;药品零售;药品批发;货物进出口;技术进出口。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114140615abbfcd7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114140615abbfcd7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","BK1191","BK1574","688185","06185"],"gpt_icon":0},{"id":"2483013073","title":"康希诺生物(06185)下跌5.01%，报31.3元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483013073","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483013073?lang=zh_cn&edition=full","pubTime":"2024-11-13 10:25","pubTimestamp":1731464747,"startTime":"0","endTime":"0","summary":"11月13日，康希诺生物(06185)盘中下跌5.01%，截至10:25，报31.3元/股，成交2990.13万元。康希诺生物股份公司是一家专注于疫苗研发、生产和商业化的高科技生物制品企业，其主要产品包括新冠疫苗、四价流脑结合疫苗、二价流脑结合疫苗和重组埃博拉病毒病疫苗等。公司已在香港和上海两地上市，拥有全球创新的五大技术平台，已建立数十条产品研发管线，并在中国天津、上海以及墨西哥、巴基斯坦、马来西亚等国家建立了大规模现代化疫苗产业基地。截至2024年三季报，康希诺生物营业总收入5.67亿元、净利润-2.22亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/13102545231733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06185","BK1515","BK1574","BK1191","BK1161"],"gpt_icon":0},{"id":"1125717540","title":"港股异动 | 恒生指数跌破2万点大关！美团、中兴通讯跌超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125717540","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125717540?lang=zh_cn&edition=full","pubTime":"2024-11-12 13:15","pubTimestamp":1731388507,"startTime":"0","endTime":"0","summary":"11月12日，恒生指数午后跌破2万点大关，$美团-W(03690)$、$中兴通讯(000063)$、$康希诺生物(06185)$跌超6%，$蔚来(NIO)$SW跌超5%，$万国数据(GDS)$跌近4%。","market":"us","thumbnail":"https://static.tigerbbs.com/76824cd4c5b97eaacdaab63d96995a28","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/76824cd4c5b97eaacdaab63d96995a28"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4a5022259c2015a48b3f97cac68d2ca4","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0307460666.USD","MPNGY","BK0103","LU0067412154.USD","LU0370786039.SGD","HSImain","LU1580142542.USD","BK1191","LU0054450605.USD","LU0211977185.USD","000063","07226","BK0196","06185","LU1328615791.USD","LU0051755006.USD","BK1610","LU0011963245.USD","00763","LU0348788117.USD","BK0167","BK1161","MHImain","BK0030","03690","HSCEI","YANG","HSI"],"gpt_icon":0},{"id":"2482279793","title":"康希诺生物盘中异动 早盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482279793","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482279793?lang=zh_cn&edition=full","pubTime":"2024-11-12 09:40","pubTimestamp":1731375610,"startTime":"0","endTime":"0","summary":"2024年11月12日早盘09时40分，康希诺生物股票出现异动，股价大幅下跌5.05%。截至发稿，该股报33.850港元/股，成交量77.6万股，换手率0.58%，振幅5.05%。机构评级方面，在所有8家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康希诺生物股票所在的生物技术行业中，整体跌幅为0.24%。康希诺生物公司简介：许可项目:第三类医疗器械经营;药品生产;药品进出口;药品零售;药品批发;货物进出口;技术进出口。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111209401098e41eb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111209401098e41eb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","06185","688185","BK1515","BK1161"],"gpt_icon":0},{"id":"2482273704","title":"港股异动 | 康希诺生物(06185)涨幅扩大逾18% 流脑疫苗快速推广 三季度公司收入同比增超76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482273704","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482273704?lang=zh_cn&edition=full","pubTime":"2024-11-11 15:35","pubTimestamp":1731310527,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康希诺生物涨幅扩大逾18%，截至发稿，涨16.64%，报36.1港元，成交额2.72亿港元。消息面上，康希诺生物近日公布，前三季度营业收入为5.67亿元人民币，同比增长222.88%；亏损达2.22亿元。单看第三季度，营业收入为2.64亿元，同比增长76.09%，纯利为296.4万元，同比扭亏为盈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1574","159646","BK1161","06185","BK1515"],"gpt_icon":0},{"id":"2482221149","title":"康希诺生物(06185)股价上升8.078%，现价港币$33.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2482221149","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482221149?lang=zh_cn&edition=full","pubTime":"2024-11-11 13:53","pubTimestamp":1731304380,"startTime":"0","endTime":"0","summary":"[上升股]康希诺生物(06185) 股价在下午01:53比前收市价上升8.078%，现股价为港币$33.45。至目前为止，今日最高价为$33.45，而最低价为$30.45。总成交量为231.266万股，总成交金额为港币$7.418千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2411111634/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK1574","BK1191","06185","BK1515"],"gpt_icon":0},{"id":"2482722308","title":"康希诺生物(06185)上涨5.17%，报32.55元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482722308","media":"金融界","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482722308?lang=zh_cn&edition=full","pubTime":"2024-11-11 13:11","pubTimestamp":1731301866,"startTime":"0","endTime":"0","summary":"11月11日，康希诺生物(06185)盘中上涨5.17%，截至13:11，报32.55元/股，成交5141.3万元。康希诺生物股份公司是一家专注于疫苗研发、生产和商业化的高科技生物制品企业，其主要产品包括新冠疫苗、四价流脑结合疫苗、二价流脑结合疫苗和重组埃博拉病毒病疫苗等。公司已在香港和上海两地上市，拥有全球创新的五大技术平台，已建立数十条产品研发管线，并在中国天津、上海以及墨西哥、巴基斯坦、马来西亚等国家建立了大规模现代化疫苗产业基地。截至2024年三季报，康希诺生物营业总收入5.67亿元、净利润-2.22亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/11131145138421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1515","BK1574","06185","BK1191","BK1161"],"gpt_icon":0},{"id":"2482234452","title":"康希诺生物盘中异动 股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482234452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482234452?lang=zh_cn&edition=full","pubTime":"2024-11-11 13:11","pubTimestamp":1731301864,"startTime":"0","endTime":"0","summary":"2024年11月11日下午盘13时11分，康希诺生物股票出现异动，股价大幅上涨5.17%。截至发稿，该股报32.550港元/股，成交量162.066万股，换手率1.22%，振幅6.79%。机构评级方面，在所有8家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康希诺生物股票所在的生物技术行业中，整体跌幅为0.13%。康希诺生物公司简介：许可项目:第三类医疗器械经营;药品生产;药品进出口;药品零售;药品批发;货物进出口;技术进出口。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111113110498e41b12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111113110498e41b12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","BK1574","06185","BK1161","688185"],"gpt_icon":0},{"id":"1123729565","title":"异动解读 | 康希诺生物业绩向好 流脑疫苗销售火爆 股价大涨近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123729565","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123729565?lang=zh_cn&edition=full","pubTime":"2024-11-10 11:14","pubTimestamp":1731208493,"startTime":"0","endTime":"0","summary":"2024年11月8日,生物科技公司康希诺生物(06185)盘中股价大涨9.74%,引发市场广泛关注。消息显示,公司前三季度业绩表现亮眼,带动投资者和机构对其前景更加看好。\n\n公司前三季度营业收入达5.67亿元,同比大增222.88%。其中,旗舰产品流脑疫苗销售收入5.16亿元,同比增长39.07%,成为营收主要贡献力量。康希诺生物财报数据还显示,第三季度实现扭亏为盈,净利润296.4万元。\n\n业内人士认为,康希诺生物营收和利润的双双大增,体现出其业务拓展及精细化费用控制措施取得成效。未来,流脑疫苗放量预期将继续支撑公司业绩向好。多家机构看好公司发展前景,给予\"买入\"评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06185"],"gpt_icon":0},{"id":"1189826698","title":"异动解读 | 康希诺生物业绩向好 流脑疫苗销售火爆 股价大涨8.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189826698","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189826698?lang=zh_cn&edition=full","pubTime":"2024-11-08 11:12","pubTimestamp":1731035525,"startTime":"0","endTime":"0","summary":"2024年11月8日,康希诺生物(06185)股价大涨8.35%,引发市场高度关注。公司近期公告数据显示,其前三季度营业收入同比大增222.88%至5.67亿元,净亏损收窄至2.22亿元。\n\n业绩增长主要得益于公司流脑疫苗产品销售收入同比增长39.07%至5.16亿元。公司精细化费用控制措施亦取得效果,第三季度实现扭亏为盈,盈利296.4万元。\n\n整体来看,康希诺生物主打产品流脑疫苗表现强劲,带动营收和利润双双大幅增长,迎来业绩拐点。市场预计公司下半年业绩有望继续向好。在此背景下,公司今日股价大涨,投资者和机构对其前景前景普遍看好。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06185"],"gpt_icon":0},{"id":"2481160462","title":"港股异动 | 康希诺生物(06185)早盘涨近8% 前三季度流脑疫苗产品销售收入同比增近四成","url":"https://stock-news.laohu8.com/highlight/detail?id=2481160462","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481160462?lang=zh_cn&edition=full","pubTime":"2024-11-08 10:53","pubTimestamp":1731034390,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康希诺生物早盘涨近8%，截至发稿，涨7.83%，报31港元，成交额5540.68万港元。消息面上，康希诺生物近期公告，公司前三季度营业收入5.67亿元，同比增加222.88%，净亏损2.22亿元。期内流脑疫苗产品销售收入5.16亿元，同比增长39.07%。第三季度，公司营业收入2.64亿元，同比增长76.09%；归属于上市公司股东的净利润296.4万元，同比实现扭亏为盈。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208353.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06185","BK1515","BK1574","BK1191","159646","BK1161"],"gpt_icon":0},{"id":"2481161990","title":"康希诺生物盘中异动 早盘大幅上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481161990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481161990?lang=zh_cn&edition=full","pubTime":"2024-11-08 10:03","pubTimestamp":1731031384,"startTime":"0","endTime":"0","summary":"2024年11月08日早盘10时03分，康希诺生物股票出现异动，股价大幅拉升5.22%。截至发稿，该股报30.250港元/股，成交量67.78万股，换手率0.51%，振幅4.35%。康希诺生物股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，科济药业-B、帝王国际投资、康宁杰瑞制药-B涨幅较大，振幅较大的相关个股有科济药业-B、康宁杰瑞制药-B、帝王国际投资，振幅分别为29.66%、19.64%、15.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108100304971a53da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108100304971a53da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","06185","BK0239"],"gpt_icon":0},{"id":"2479219292","title":"【港股通】康希诺生物(06185)AH股齐走高 第三季度营收增长76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479219292","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479219292?lang=zh_cn&edition=full","pubTime":"2024-10-30 11:16","pubTimestamp":1730258211,"startTime":"0","endTime":"0","summary":"金吾财讯 | 康希诺生物(06185)早盘股价逆市走高，截至发稿，报28.5港元，涨8.78%，成交额1.07亿港元。另外，对应A股康希诺(688185)同步上扬，惟升幅稍逊，暂报57.99元人民币，涨3.91%。消息面上，第三季度，公司营业收入2.64亿元(人民币下同)，同比增长76.09%；归属于上市公司股东的净利润296.4万元，归属于上市公司股东的扣除非经常性损益的净亏损672万元。至于首三季营业收入为5.67亿元，按年增222.88%，亏损达2.22亿元，基本每股亏损为0.9元。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/MDI1YTMwZTQxYzhhNDE2OTgwYTUxYmYyODYyMzUwODkzNDM3NDk5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MDI1YTMwZTQxYzhhNDE2OTgwYTUxYmYyODYyMzUwODkzNDM3NDk5.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1946759","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSCEI","HSTECH","YANG","06185"],"gpt_icon":0},{"id":"2479281213","title":"《股市简讯》康希诺中港股齐飙，前三季同比大幅减亏、三季度实现盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2479281213","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479281213?lang=zh_cn&edition=full","pubTime":"2024-10-30 10:39","pubTimestamp":1730255998,"startTime":"0","endTime":"0","summary":"《股市简讯》康希诺中港股齐飙，前三季同比大幅减亏、三季度实现盈利* 中国康希诺688185.SS6185.HK中港股周三双双攀升，分别一度飙涨7.3%和14.5%，公司三季度同比扭亏为盈。该公司称，去年同期受到新冠疫苗预估退货影响，共计冲减营业收入2.4亿元，剔除该影响，去年同期本集团实现营业收入4.1亿元，按此数据计算，前三季度营业收入同比增长 36.85%。公司并称，营业收入增长以及费用管控和整体经营效率的提高，使得前三季度大幅减亏，并实现三季度单季盈利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nL4T3M606Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688185","BK1191","BK1161","BK0239","BK1515","06185","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cansinotech.com","stockEarnings":[{"period":"1week","weight":-0.2076},{"period":"1month","weight":0.1277},{"period":"3month","weight":0.4729},{"period":"6month","weight":0.3232},{"period":"1year","weight":0.0482},{"period":"ytd","weight":0.1996}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.059},{"period":"3month","weight":0.118},{"period":"6month","weight":0.0198},{"period":"1year","weight":0.1216},{"period":"ytd","weight":0.1484}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康希诺生物股份公司是一家处于临床阶段的中国疫苗公司。该公司的产品包括埃博拉病毒疫苗Ad5-EBOV、脑膜炎球菌疫苗MCV2和MCV4、肺炎球菌疫苗PBPV和重组新型冠状病毒疫苗等。其产品主要应用于脑膜炎、百白破和肺炎领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.023945},{"month":2,"riseRate":0.8,"avgChangeRate":0.176312},{"month":3,"riseRate":0.2,"avgChangeRate":-0.039813},{"month":4,"riseRate":0.666667,"avgChangeRate":0.073414},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.048095},{"month":6,"riseRate":0.5,"avgChangeRate":0.040455},{"month":7,"riseRate":0.5,"avgChangeRate":0.015509},{"month":8,"riseRate":0,"avgChangeRate":-0.182296},{"month":9,"riseRate":0.666667,"avgChangeRate":0.077531},{"month":10,"riseRate":0.5,"avgChangeRate":0.079945},{"month":11,"riseRate":0.666667,"avgChangeRate":0.128255},{"month":12,"riseRate":0.6,"avgChangeRate":-0.050745}],"exchange":"SEHK","name":"康希诺生物","nameEN":"CANSINOBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康希诺生物(06185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康希诺生物(06185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康希诺生物,06185,康希诺生物股票,康希诺生物股票老虎,康希诺生物股票老虎国际,康希诺生物行情,康希诺生物股票行情,康希诺生物股价,康希诺生物股市,康希诺生物股票价格,康希诺生物股票交易,康希诺生物股票购买,康希诺生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康希诺生物(06185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康希诺生物(06185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}